RESEARCH ARTICLE
Nobel Med 2015; 11(1): 87-91

THE IMPORTANCE OF SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR IN PATIENTS WITH ACUTE BRUCELLOSIS

Nazlım Aktuğ Demir, Hatice Türk Dağı, Duygu Fındık, Şua Sümer, Onur Ural, Servet Kölgelier
ABSTRACT
Objective: Brucellosis is a common zoonotic infectious disease especially in Mediterranean countries. Inflammatory markers are elevated during the course of acute brucellosis. C-reactive protein (CRP) is the most commonly used biochemical marker in clinical practice. Soluble urokinase type plasminogen activator receptor (suPAR) is an interesting biomarker which has drawn attention recently. Purpose of this study is to examine correlation between suPAR and CRP levels as markers of infectious disease in patients diagnosed with acute brucellosis.

Material and Method: This study included 125 acute brucellosis patients and 50 healthy controls. Pretreatment blood samples were taken from the patients. suPAR levels were measured using ELISA and CRP levels were measured with nephelometry.
Results: There was a positive correlation between suPAR levels and CRP, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) (p=0.045, 0.039, 0.040; respectively). When we compared patient and control groups, CRP and suPAR levels were significantly higher than controls (p=0.001, 0.001; respectively). Growth in blood culture was detected in 14 (11.2%) patients. There was not a significant difference between patients who have or did not have growth in blood cultures (p=0.117). In the ROC curve analysis performed for suPAR, area under the curve (AUC) was 93.6% (p=0.001). Sensitivity and specificity were calculated as 84.8% and 86.0%, respectively, when suPAR’s cut-off value was taken as 3.85 ng/mL according to the ROC curve.

Conclusion: Results of this study suggest that suPAR, like CRP, is a promising biomarker in acute brucellosis.

THE PERSPECTIVE OF INTERNATIONAL CLASSIFICATION OF FUNCTIONING, DISABILITY, AND HEALTH (ICF) IN OBESITY

05-13

Sina Esmaeilzadeh, Merih Akpınar, Aydan Oral

REVIEW Nobel Med 2015; 11(1): 05-13

RISK EVALUATION, RISK COMMUNICATION AND PERINATAL EVALUATION IN PREGNANCIES WITH DRUG EXPOSURE

14-21

Yusuf Cem Kaplan, Sefa Kelekçi, Ömer Demir

REVIEW Nobel Med 2015; 11(1): 14-21

INVESTIGATION OF GENOTOXICITY IN INTESTINAL EPITHELIAL CELLS AND LYMPHOCYTES OF CELIAC PATIENTS

22-26

Özlem Yüce, Ayhan Gazi Kalaycı, Ali Okuyucu, Gönül Caltepe, Abdulkerim Bedir

RESEARCH ARTICLE Nobel Med 2015; 11(1): 22-26

RELATIONSHIP OF DOMESTIC PHYSICAL VIOLENCE AND SEVERITY OF PAIN, DEPRESSION AND ANXIETY LEVELS IN FIBROMYALGIA CASES

27-32

Ürün Özer, Esra Selimoğlu, Engin Badur, Ersin Uygun, Çağatay Karşıdağ

RESEARCH ARTICLE Nobel Med 2015; 11(1): 27-32

HIP PAIN IN PREGNANCY

33-36

Metin Uzun , Ercan Baştu, Burak Beksaç, Adnan Kara, Müjdat Adaş

RESEARCH ARTICLE Nobel Med 2015; 11(1): 33-36

EVALUATION OF SECONDARY AND TERTIARY HEALTH CENTERS EMERGENCY SERVICE APPLICATIONS DUE TO SUICIDAL ATTEMPTS

37-42

Binali Çatak, Can Öner, Sevgi Baştürk, Oya Karaali, İrfan Oğuz, Resul Özbek

RESEARCH ARTICLE Nobel Med 2015; 11(1): 37-42

EFFECT OF INTRAOPERATIVE MEAN BLOOD PRESSURE ON POSTOPERATIVE COGNITIVE FUNCTION IN GERIATRIC PATIENTS WITH HYPERTENSION

43-48

Pınar Özlülerden, Seher İlhan, İbrahim Öztürk, Hakan Erbay

RESEARCH ARTICLE Nobel Med 2015; 11(1): 43-48

INFLUENCE OF SEASONALITY ON SUICIDAL HANGING IN ISTANBUL, 1979-2012: ASSOCIATIONS WITH GENDER, AGE, LOCATION AND INSTRUMENTS OF SUICIDE

49-54

Bahadır Kumral, Şafak Taktak, Ayla Ünsal, Taşkın Özdeş, Yalçın Büyük, Rıfat O. Özdemirel

RESEARCH ARTICLE Nobel Med 2015; 11(1): 49-54

SCALE DEVELOPMENT STUDY ON ETHICAL PROBLEMS: AN APPLICATION ON MEDICAL STUDENTS

55-63

Engin Kurt, Ahmet Keser, Yunus Gökmen

RESEARCH ARTICLE Nobel Med 2015; 11(1): 55-63

FREQUENCY AND THE FACTORS AFFECTING VIOLENCE TOWARDS PREGNANT WOMAN ADMITTED TO A UNIVERSITY HOSPITAL PREGNANCY OUTPATIENT CLINIC

64-70

Filiz Bolu, Atilla Senih Mayda, Muammer Yılmaz

RESEARCH ARTICLE Nobel Med 2015; 11(1): 64-70

COMPARISON OF PULSE OXYMETER AND CEREBRAL OXYMETER VALUES IN HEALTHY NEWBORNS IN THE FIRST FIVE MINUTES OF LIFE

71-75

Gökmen A. Taşkın, Avni Kaya, Ertan Sal, Lokman Üstyol, Erdal Peker, Oğuz Tuncer, Ercan Kırımi

RESEARCH ARTICLE Nobel Med 2015; 11(1): 71-75

COMPARISON OF EFFICACY AND SAFETY OF LOTEPREDNOL ETABONATE 0.5% VERSUS FLUOROMETHOLONE ACETAT 0.1% FOR THE TREATMENT OF VERNAL KERATOCONJUNCTIVITIS IN PEDIATRIC SUBJECTS

76-82

Mustafa Eliaçık, Fırat Erdoğan, Hüseyin Bayramlar, Sevil Karaman, Gökhan Gülkılık

RESEARCH ARTICLE Nobel Med 2015; 11(1): 76-82

SERUM TOTAL OXIDATIVE AND ANTIOXIDATIVE STATUS IN PATIENTS WITH POSTMENOPAUSAL OSTEOPOROSIS

83-86

Ercan Madenci, Şükrü Güçbey, İrfan Koca, Erhan İbas, Hülya Çiçek

RESEARCH ARTICLE Nobel Med 2015; 11(1): 83-86

THE IMPORTANCE OF SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR IN PATIENTS WITH ACUTE BRUCELLOSIS

87-91

Nazlım Aktuğ Demir, Hatice Türk Dağı, Duygu Fındık, Şua Sümer, Onur Ural, Servet Kölgelier

RESEARCH ARTICLE Nobel Med 2015; 11(1): 87-91

BREAST MALIGNANCY WITH LESER-TRELAT SIGN IN A GERIATRIC PATIENT

92-93

Pınar Yıldız, Hayrettin Dizen, Mustafa Yıldız, Ahmet Volkan Yıldırım

REPORT Nobel Med 2015; 11(1): 92-93

PITUITARY ADRENAL INSUFFICIENCY IN A CANCER PATIENT UNDER OPIOID TREATMENT

94-96

Fatma Avcı Merdin, Alparslan Merdin, Melek Karakurt Eryılmaz, Safiye Arık, Şeyda Gündüz, Hasan Şenol Coşkun, Hasan Altunbaş

REPORT Nobel Med 2015; 11(1): 94-96

CHOROIDAL NEOVASCULAR MEMBRANE ASSOCIATED WITH SILDENAFIL

97-99

Harun Çakmak, Sema Oruç Dündar, Tolga Kocatürk

REPORT Nobel Med 2015; 11(1): 97-99

SAFİYE ALİ

100-102

Doç. Dr. İnci Hot

A PORTRAIT Nobel Med 2015; 11(1): 100-102
  • Pubmed Style
    Nazlım Aktuğ Demir, Hatice Türk Dağı, Duygu Fındık, Şua Sümer, Onur Ural, Servet Kölgelier. [THE IMPORTANCE OF SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR IN PATIENTS WITH ACUTE BRUCELLOSIS]. Nobel Med 2015; 11(1): 87-91, English.
  • Web Style
    Nazlım Aktuğ Demir, Hatice Türk Dağı, Duygu Fındık, Şua Sümer, Onur Ural, Servet Kölgelier. [THE IMPORTANCE OF SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR IN PATIENTS WITH ACUTE BRUCELLOSIS]. www.nobelmedicus.com/en/Article.aspx?m=1716 [Access: Mayıs 24, 2021], English.
  • AMA (American Medical Association) Style
    Nazlım Aktuğ Demir, Hatice Türk Dağı, Duygu Fındık, Şua Sümer, Onur Ural, Servet Kölgelier. [THE IMPORTANCE OF SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR IN PATIENTS WITH ACUTE BRUCELLOSIS]. Nobel Med 2015; 11(1): 87-91, English.
  • Vancouver/ICMJE Style
    Nazlım Aktuğ Demir, Hatice Türk Dağı, Duygu Fındık, Şua Sümer, Onur Ural, Servet Kölgelier. [THE IMPORTANCE OF SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR IN PATIENTS WITH ACUTE BRUCELLOSIS]. Nobel Med (2015); 11(1): 87-91, [cited Mayıs 24, 2021], English.
  • Harvard Style
    Nazlım Aktuğ Demir, Hatice Türk Dağı, Duygu Fındık, Şua Sümer, Onur Ural, Servet Kölgelier. (2015) [THE IMPORTANCE OF SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR IN PATIENTS WITH ACUTE BRUCELLOSIS]. Nobel Med, 11(1): 87-91, English.